Literature DB >> 22021613

Osteopontin modulates the generation of memory CD8+ T cells during influenza virus infection.

Junko Morimoto1, Kayoko Sato, Yosuke Nakayama, Chiemi Kimura, Kiichi Kajino, Yutaka Matsui, Tadaaki Miyazaki, Toshimitsu Uede.   

Abstract

The adaptive immune system generates memory cells, which induce a rapid and robust immune response following secondary Ag encounter. Memory CD8(+) T cells are a critical component of protective immunity against infections and cancers. Therefore, understanding the mechanism whereby memory CD8(+) T cells are generated and maintained is important for inducing effective memory CD8(+) T cell response. Recent studies have demonstrated that the inflammatory cytokine IL-12 favors the generation of terminal effector CD8(+) T cells rather than memory precursor effector CD8(+) T cells by regulating the expression of the transcription factor T-bet. In this study, we report that the inflammatory cytokine osteopontin (Opn) modulates memory CD8(+) T cell generation during influenza virus infection. Although Opn wild-type and Opn knockout (KO) mice had similar numbers of virus-specific effector CD8(+) T cells, virus-specific effector CD8(+) T cells generated in Opn KO mice showed low levels of T-bet expression and an increased memory precursor cell population compared with cells generated in Opn wild-type mice. This resulted in the persistently increased number of memory CD8(+) T cells in Opn KO mice. Studies with bone marrow-derived dendritic cells demonstrated that Opn deficiency in bone marrow-derived dendritic cells results in low levels of IL-12 production in response to the stimulation with influenza virus. Thus, we hypothesize that Opn modulates the generation of memory precursor effector CD8(+) T cells by regulating cytokine milieu during the acute phase of virus infection. This finding may provide new insight into the role of Opn in adaptive immune response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22021613     DOI: 10.4049/jimmunol.1101825

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant.

Authors:  Jan Tavernier; Sarah Gerlo; Bram Van Den Eeckhout; Lien Van Hoecke; Elianne Burg; Sandra Van Lint; Frank Peelman; Niko Kley; Gilles Uzé; Xavier Saelens
Journal:  NPJ Vaccines       Date:  2020-07-23       Impact factor: 7.344

Review 2.  Asymptomatic memory CD8+ T cells: from development and regulation to consideration for human vaccines and immunotherapeutics.

Authors:  Arif Azam Khan; Ruchi Srivastava; Patricia Prado Lopes; Christine Wang; Thanh T Pham; Justin Cochrane; Nhi Thi Uyen Thai; Lucas Gutierrez; Lbachir Benmohamed
Journal:  Hum Vaccin Immunother       Date:  2014-02-05       Impact factor: 3.452

3.  Quinolone-induced upregulation of osteopontin gene promoter activity in human lung epithelial cell line A549.

Authors:  Beata Shiratori; Jing Zhang; Osamu Usami; Haorile Chagan-Yasutan; Yasuhiko Suzuki; Chie Nakajima; Toshimitsu Uede; Toshio Hattori
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

4.  Osteopontin Regulates Hepatitis C Virus (HCV) Replication and Assembly by Interacting with HCV Proteins and Lipid Droplets and by Binding to Receptors αVβ3 and CD44.

Authors:  Jawed Iqbal; Mehuli Sarkar-Dutta; Steven McRae; Akshaya Ramachandran; Binod Kumar; Gulam Waris
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

5.  OSTEOPONTIN: A KEY LINK BETWEEN IMMUNITY, INFLAMMATION AND THE CENTRAL NERVOUS SYSTEM.

Authors:  Amanda Brown
Journal:  Transl Neurosci       Date:  2012-02-01       Impact factor: 1.757

6.  Utility of Plasma Osteopontin Levels in Management of Community-Acquired Pneumonia.

Authors:  Jer-Hwa Chang; Wen-Yueh Hung; Kuan-Jen Bai; Shun-Fa Yang; Ming-Hsien Chien
Journal:  Int J Med Sci       Date:  2016-08-10       Impact factor: 3.738

7.  Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant.

Authors:  Jan Tavernier; Sarah Gerlo; Bram Van Den Eeckhout; Lien Van Hoecke; Elianne Burg; Sandra Van Lint; Frank Peelman; Niko Kley; Gilles Uzé; Xavier Saelens
Journal:  NPJ Vaccines       Date:  2020-07-23       Impact factor: 7.344

8.  A two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge.

Authors:  Wenwen Jiang; Li Shi; Lukui Cai; Xiaoyu Wang; Jingyan Li; Heng Li; Jiangli Liang; Qin Gu; Guang Ji; Jing Li; Longding Liu; Mingbo Sun
Journal:  Cell Rep       Date:  2021-11-24       Impact factor: 9.423

9.  Respiratory syncytial virus (RSV) infection in elderly mice results in altered antiviral gene expression and enhanced pathology.

Authors:  Terianne M Wong; Sandhya Boyapalle; Viviana Sampayo; Huy D Nguyen; Raminder Bedi; Siddharth G Kamath; Martin L Moore; Subhra Mohapatra; Shyam S Mohapatra
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.